CS-121

BIOLOGICAL3 trials

Sponsors

CorrectSequence Therapeutics Co., Ltd, Shanghai Jiao Tong University School of Medicine

Conditions

Familial Chylomicronemia Syndrome (FCS)HyperchylomicronemiaSevere Hypertriglyceridemia (sHTG)

Early Phase 1

CS-121 APOC3 Base Editing in FCS

RecruitingNCT07176923

CorrectSequence Therapeutics Co., LtdFamilial Chylomicronemia Syndrome (FCS)

Start: 2025-10-15End: 2026-12-01Target: 15Updated: 2026-02-11

CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia

RecruitingNCT07371767

Shanghai Jiao Tong University School of MedicineHyperchylomicronemia

Start: 2026-01-26End: 2041-01-31Target: 15Updated: 2026-01-28

CS-121 APOC3 Base Editing in Severe Hypertriglyceridemia

Not yet recruitingNCT07657780

CorrectSequence Therapeutics Co., LtdSevere Hypertriglyceridemia (sHTG)

Start: 2026-06-15End: 2028-07-31Target: 15Updated: 2026-06-18